Oncowin cancer center

Dr. Rushabh Kothari

Education / Qualification

DM Medical Oncology, ECMO (Europe),
Co-founder of Oncowin Cancer Center

Dr. Rushabh Kothari is one of the most promising names for treating cancer and saving lives. Dr. Kothari was into treating his every case understanding it in thorough detail. Going by his patient reviews, Dr. Kothari makes his patient believe in the treatment process and solve their queries. Completed his MBBS from Smt. NHL Municipal Medical College, Ahmedabad, MD from Lokmanya Tilak Municipal Medical College, Mumbai, DM in Medical Oncology Tata Memorial Hospital, Mumbai.

He is always available for his patient and covers complete care right from diagnosis to end of treatment. Dr. Kothari's keen interest is to provide every patient with advanced and comprehensive treatment in a seamless flow.

According to Dr. Rushabh, every patient is important and should be served immediately without any biases.

Area of special interest

Gynecological Cancers

(Ovarian Cancer, Uterine Cancer, Cervical Cancer)

Genitourinary Cancer

(Prostate Cancer, Kidney Cancer, Urinary Bladder Cancer, Testicular Cancer)

Publications

Kothari R, Digole A, Kamat S, Nandanwar YS, Gokhale Y. Reproductive Health in Systemic Lupus Erythematosus, An experience from Government Hospital in Western India. J Assoc Physicians India. 2016 Dec;64(12):16-20.
Ramaswamy A, Joshi A, Noronha V, Patil VM, Kothari R, Sahu A, Kannan RA, Sable N, Popat P, Menon S, Prabhash K. Patterns of Care and Clinical Outcomes in Patients with Metastatic Renal Cell Carcinoma-Results from a Tertiary Cancer Center in India. Clin Genitourin Cancer. 2017 Jun;15(3): e345-e355.
Ramaswamy A, Joshi A, Noronha V, Patil V, Sahu A, Manickam DR, Kothari R,Sable N, Agrawal A, Menon S, Prabhash K. Poor Risk Advanced Renal Cell Carcinoma: Outcomes from a Registry in a Tertiary Cancer Center. Indian J Med Paediatr Oncol. 2017 Jul-Sep;38(3):311-315.
Gokhale Y, Raut A, Lala DK, Kothari R, Kalekar L, Kamble A. Etiology and Outcomes of Lower Limb Ulcers in Non-Diabetic Patients, An Experience from Government Hospital in Western India. J Assoc Physicians India. 2017 Nov;65(11):47-50.
Patil VM, Tonse R, Kothari R, Chandrasekaran A, Pande N, Epari S, Gupta T,Jalali R. Rechallenge temozolomide in glioma: A case series from India. Indian J Cancer. 2017 Jan-Mar;54(1):368-371.
Ramaswamy A, Kothari R, Desouza A, Saklani A, Ostwal V, Gupta T, et al. Adjuvant chemotherapy in stage II-III operated colon cancer patients from a nontribal cohort in a low colon cancer prevalence country with predominant use of modified CAPOX. South Asian Journal of Cancer July 2019;8(3):160
Ramaswamy A, Parthiban S, Malhotra M, Kothari R, Ostwal V, et al. Outcomes of second line chemotherapy in advanced pancreatic cancers: Aretrospective study from tertiary care centre in India. Indian J Cancer. April 2018;55(2):144-147
Chichra A, Nayak L, Kothari R, Bonda A, Gokarn A, Khattry N, et al. Fludarabine Melphalan versus Fludarabine Treosulfan as Reduced Intensity Conditioning Regimens in Allogenic Hematopoietic Stem Cell Transplant- a Retrospective Analysis. Blood November 2019(supplement_1): 4493-4493
Kothari R. Things I wish I had learned during residency- Practical Tips. Cancer Res Stat Treat 2020;3 552-3.